The impact of glutamate infusion on postoperative NT-proBNP in patients undergoing coronary artery bypass surgery: a randomized study.
Huiqi JiangJonas HolmMårten VidlundFarkas VankyÖrjan FribergYanqi YangRolf SvedjeholmPublished in: Journal of translational medicine (2020)
Post hoc analysis of postoperative NT-proBNP suggests that intravenous infusion of glutamate may prevent or mitigate myocardial dysfunction in high-risk patients undergoing CABG. Further studies are necessary to confirm these findings. Trial registration Swedish Medical Products Agency 151:2003/70403 (prospectively registered with amendment about this substudy filed March 17, 2007). ClinicalTrials.gov Identifier: NCT00489827 (retrospectively registered) https://clinicaltrials.gov/ct2/show/NCT00489827?term=glutamics&draw=1&rank=1.
Keyphrases
- coronary artery bypass
- patients undergoing
- percutaneous coronary intervention
- low dose
- healthcare
- study protocol
- computed tomography
- clinical trial
- high dose
- preterm infants
- left ventricular
- oxidative stress
- phase iii
- image quality
- contrast enhanced
- phase ii
- coronary artery disease
- dual energy
- acute coronary syndrome
- coronary artery bypass grafting
- magnetic resonance imaging
- risk assessment
- positron emission tomography
- atrial fibrillation
- open label